Bengaluru-based biopharma company PlasmaGen Biosciences has raised Rs 150 crore led by ViNS Bioproducts along with participation from high-net-worth individuals, family offices, pharma entrepreneurs, and existing investors. The startup is backed by Eight Road Ventures secured the funding at a valuation of over Rs 1,500 crore.
PlasmaGen has mopped up over Rs 600 crore in funding to date from Fidelity’s FIL Capital Investments, Eight Roads Ventures, F-Prime Capital, and others.
The proceeds will be used to scale international operations, expand the…
